Rejuvenate Biomed Secures Permanent Spot in Belgian Pavilion
OSAKA/DIEPENBEEK – The Limburg-based biotech company Rejuvenate Biomed has secured a permanent place in the Belgian pavilion at the World Expo in Osaka, Japan. The company, located on the Health Campus Limburg DC in Diepenbeek, is the only representative from Limburg in the permanent exhibition during Flanders Week, from 16 to 18 June 2025. The participation is part of an international health and biotech mission coordinated by Flanders Investment & Trade (FIT).
The Flemish delegation, led by Minister-President Matthias Diependaele, consists of leading companies, universities, and government organizations. Under the overarching theme Saving Lives, Belgium presents itself in Osaka as an innovative frontrunner in healthcare and biotech. From Limburg, POM Limburg and Health Campus Limburg DC are actively participating in the mission. The selection of Rejuvenate Biomed highlights the strength of the regional ecosystem for medical innovation.
“We are proud that a company from our campus is receiving this international recognition,” says Tom Vandeput, Deputy for Economy and Chairman of POM Limburg. “It confirms that Limburg is a player in biotech and healthcare, even on a global level.”
Healthy Aging as a Focus Area
Rejuvenate Biomed develops medicines for age-related diseases using artificial intelligence. This technology enables them to take into account the general biology of the aging process. Their clinical phase 2 product, RJx-01, shows promising results for the treatment of sarcopenia, a condition in which muscle strength and function decline with age.
“We want to fundamentally rethink the treatment of age-related diseases by acknowledging that our ability to recover declines with age,” says founder and CEO Dr. Ann Beliën. “Our approach fits perfectly within the Saving Lives philosophy of the Belgian pavilion. We are building a healthier future for everyone.”
Limburg Innovation with a Japanese Link
Rejuvenate Biomed supports research into healthy aging, in collaboration with UHasselt. An innovative platform is being developed to measure how cells age and to detect disease characteristics at an early stage. The project is part of SALKturbo and receives support from the European Regional Development Fund (ERDF).
The mission to Japan gains additional significance through the link with Okinawa, a Japanese “blue zone” known worldwide for its exceptionally healthy and long-living population. That region serves as a key source of inspiration for Limburg’s research into healthy aging.
